CVRX / CVRx to Report Fourth Quarter and Fiscal Year 2022 Financial and Operating Results and Host Conference Call on January 26, 2023

CVRx (CVRX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive th more_horizontal

CVRx, Inc. (NASDAQ:CVRX ) Q3 2023 Earnings Conference Call October 26, 2023 5:30 PM ET Company Participants Mike Vallie - SVP-ICR Westwicke Nadim Yare more_horizontal

CVRx Inc's has recovered towards previous highs following the fallout of its BeAT-HF trial results in February 2023. Adoption and utilization of its B more_horizontal

CVRx, Inc. (NASDAQ:CVRX ) Q2 2023 Earnings Conference Call July 25, 2023 5:30 PM ET Company Participants Mike Vallie – Senior Vice President-ICR Wes more_horizontal

CVRx (CVRX) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.57. This compares to loss of $0.54 p more_horizontal

MINNEAPOLIS, July 11, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing more_horizontal

CVRx (CVRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions co more_horizontal

I called CVRx a highly risky but potentially lucrative investment at the time of the IPO in the summer of 2021. The company has seen solid revenue gro more_horizontal